Metraipolis › archive › dc_aa155fd42214

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances — Europe PMC PMID:41596238

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41596238
DOI
10.3390/ijms27020585
License (as archived)
solo-consultazione
Archived
2026-11-07T01:13:33.025Z
SHA-256 of the archived text
75e409425ea28085c408705691926312add0502e2ec486b295965b90173bf632
Stable URL of this page
https://metraipolis.com/documento/dc_aa155fd42214

How to cite

Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances — Europe PMC PMID:41596238 — Europe PMC (en), https://europepmc.org/article/MED/41596238 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa155fd42214 (Metraipolis archive dc_aa155fd42214, sha256 75e409425ea28085c408705691926312add0502e2ec486b295965b90173bf632)
BibTeX
@misc{dcaa155fd42214,
  title = {Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances — Europe PMC PMID:41596238},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41596238},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa155fd42214; sha256 75e409425ea28085c408705691926312add0502e2ec486b295965b90173bf632},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41596238. Agents can read the archived copy with the MCP tool read_document.